Enjoy complimentary customisation on priority with our Enterprise License!
The medical cases of infectious diseases such as hepatitis B, hepatitis C, and HIV is increasing on a global level. Research analysis in the global paper diagnostics market identifies that the increasing prevalence of infectious and lifestyle associated diseases will be one of the major factors that will have a positive impact on the paper diagnostics market size. The analysis of infectious agent requires paper diagnostic test using molecular testing or assays. Paper diagnostic is also widely used to detect urinary infections through urinalysis. The lack of medical infrastructure and low awareness in emerging economies such as Africa, Saudi Arabia, India, and South Korea is driving the incidence of infectious diseases. This, in turn, will boost the application of paper diagnostics for primary testing. According to the paper diagnostics industry analysis, Technavio’s market research analysts predict that this market will grow at a CAGR of close to 7% by 2021.
The rising awareness about the rapid testing of infectious diseases in the emerging markets such as Mexico, Brazil, and Chile is driving the growth prospects for the global paper diagnostics market in the Americas. The adoption of diagnostic paper products for Zika virus, Ebola, and use of nano-biosensors will continue to increase in the region throughout the estimated period due to the presence of sophisticated healthcare infrastructure and high patient awareness.
The paper diagnostics market is highly competitive due to the presence of major vendors. These vendors are increasingly competing against each other based on factors such as pricing, product differentiation, advances in technology, and a strong distribution channel. They are also entering into partnerships with other vendors.
Key vendors in this market are
Other prominent vendors in the market include Abcam, Abingdon Health, ACON Laboratories, ARKRAY, BBI Solutions, BIOPORTO, Chembio Diagnostic Systems, Cytodiagnostics, DCN Diagnostics, Innova Biosciences, NanoHybrids, SD Biosensor, Sigma-Aldrich (Merck Millipore), and Surmodics.
The rising incidence rate of infectious diseases and lifestyle disorders is driving the demand for paper diagnostic test across the globe. The paper diagnostics market will continue to witness growth in the lateral flow assay kits segment due to the constant changes in the lifestyle of people.
The growing incidence rate of infectious diseases such as cancer, human immunodeficiency virus (HIV), and lifestyle-associated disorders such as diabetes and pre-diabetes is responsible for the increasing sales of paper diagnostics in hospitals. Based on the paper diagnostics market outlook, this market will continue to grow in the hospital segment for the next four years due to the bulk purchase of diagnostic kits, dipsticks, and other consumables.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research methodology
PART 04: Introduction
PART 05: Market Landscape
PART 06: Market sizing
PART 07: Five forces analysis
PART 08: Market segmentation by product
PART 09: Market segmentation by end-user
PART 10: Regional landscape
PART 11: Decision framework
PART 12: Drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Vendor analysis
PART 16: Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.